Announcement on the Arbitration Result
Filed with SSE · · 6 pages · Chinese
Beijing Konruns Pharmaceutical Co., Ltd. on 6ix
Earlier from Beijing Konruns Pharmaceutical
- Announcement on Results of the Initial Grant under the 2026 Restricted Share Incentive Plan
- Announcement on Obtaining New Veterinary Drug Registration Certificate
- Announcement on Release of Trading Restrictions and Listing of Shares for the 3rd Lock-up Period of the Initial Grant under the 2023 Restricted Share Incentive Plan
- Announcement on Lifting of Restrictions and Listing of Shares for the Second Lock-up Period of Reserved Grant under the 2023 Restricted Share Incentive Plan
- Semi-annual Report for 2026
Later from Beijing Konruns Pharmaceutical
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Change of Registered Capital and Amendment to the Articles of Association
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Repurchase and Cancellation of Restricted Shares Granted to Certain Incentive Participants but Not Yet Released from Trading Restrictions
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Resolutions of the 7th Meeting of the 5th Board of Directors
Follow Beijing Konruns Pharmaceutical into a list and get an email when it puts out news.
Follow Beijing Konruns Pharmaceutical